SAR-407899

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameSAR-407899
Drug Alias NameSAR-407899SAR-407899A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRhodopsin kinase inhibitors
TargetsRhodopsin kinase
Therapy Area/IndicationsCoronary Artery DiseaseRenal Insufficiency, ChronicErectile Dysfunction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSwedenRomania +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsCoronary Artery DiseaseRenal Insufficiency, ChronicErectile Dysfunction

Other Information

ATC CodeN/A
Related LinksN/A